Symbol: SOPH




Market price today

  • -4.1295

    P/E Ratio

  • 0.0483

    PEG Ratio

  • 326.51M

    MRK Cap

  • 0.00%

    DIV Yield

SOPHiA GENETICS SA (SOPH) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO:Dr. Jurgi Camblong M.B.A., Ph.D.
Full-time employees:430
Address:Rue du Centre 172

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

General Outlook

In simple terms, SOPHiA GENETICS SA has 65.301 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.688% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -1.202%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -1.266%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.383% return, is a testament to SOPHiA GENETICS SA's adeptness in optimizing resource deployment. SOPHiA GENETICS SA's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -0.474%. Furthermore, the proficiency of SOPHiA GENETICS SA in capital utilization is underscored by a remarkable -0.440% return on capital employed.

Stock Prices

SOPHiA GENETICS SA's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $5.2, while its low point bottomed out at $4.76. This variance in figures offers investors a lucid insight into the roller-coaster ride that is SOPHiA GENETICS SA's stock market.

Liquidity Ratios

Analyzing SOPH liquidity ratios reveals its financial health of the firm. The current ratio of 415.62% gauges short-term asset coverage for liabilities. The quick ratio (388.69%) assesses immediate liquidity, while the cash ratio (346.01%) indicates cash reserves.

Current Ratio415.62%
Quick Ratio388.69%
Cash Ratio346.01%

Profitability Ratios

SOPH profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -125.85% underscores its earnings before tax deductions. The effective tax rate stands at -0.62%, revealing its tax efficiency. The net income per EBT, 100.62%, and the EBT per EBIT, 104.69%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -120.21%, we grasp its operational profitability.

Pretax Profit Margin-125.85%
Effective Tax Rate-0.62%
Net Income per EBT100.62%
EBT per EBIT104.69%
EBIT per Revenue-120.21%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 4.16, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations. Meanwhile, a 3 cash conversion cycle and 410.20% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding389
Days of Inventory Outstanding122
Operating Cycle210.57
Days of Payables Outstanding101
Cash Conversion Cycle109
Receivables Turnover4.10
Payables Turnover3.61
Inventory Turnover3.00
Fixed Asset Turnover2.70
Asset Turnover0.30

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.74, and free cash flow per share, -0.88, depict cash generation on a per-share basis. The cash per share value, 1.89, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.77, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.74
Free Cash Flow per Share-0.88
Cash per Share1.89
Operating Cash Flow Sales Ratio-0.77
Free Cash Flow to Operating Cash Flow Ratio1.19
Cash Flow Coverage Ratio-2.60
Short Term Coverage Ratio-16.49
Capital Expenditure Coverage Ratio-5.26
Dividend Paid and Capex Coverage Ratio-5.26

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 9.02%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.12, we discern the balance between debt and equity financing. The long-term debt to capitalization, 9.38%, and total debt to capitalization, 10.94%, ratios shed light on its capital structure. An interest coverage of -47.39 indicates its ability to manage interest expenses.

Debt Ratio9.02%
Debt Equity Ratio0.12
Long Term Debt to Capitalization9.38%
Total Debt to Capitalization10.94%
Interest Coverage-47.39
Cash Flow to Debt Ratio-2.60
Company Equity Multiplier1.36

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.96, provides a glimpse into top-line earnings distributed across each share. Net income per share, -1.22, reflects the portion of profit attributed to each share. The book value per share, 2.34, represents the net asset value distributed per share, while the tangible book value per share, 1.92, excludes intangible assets.

Revenue Per Share0.96
Net Income Per Share-1.22
Book Value Per Share2.34
Tangible Book Value Per Share1.92
Shareholders Equity Per Share2.34
Interest Debt Per Share0.30
Capex Per Share-0.14

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 31.14%, indicates top-line expansion, while the gross profit growth, 17.35%, reveals profitability trends. EBIT growth, 12.43%, and operating income growth, 12.43%, offer insights into operational profitability progression. The net income growth, 9.68%, showcases bottom-line expansion, and the EPS growth, 10.29%, measures the growth in earnings per share.

Revenue Growth31.14%
Gross Profit Growth17.35%
EBIT Growth12.43%
Operating Income Growth12.43%
Net Income Growth9.68%
EPS Growth10.29%
EPS Diluted Growth10.29%
Weighted Average Shares Growth1.02%
Weighted Average Shares Diluted Growth1.02%
Operating Cash Flow Growth30.70%
Free Cash Flow Growth28.17%
3-Year Revenue Growth per Share116.59%
3-Year Operating CF Growth per Share-50.98%
3-Year Net Income Growth per Share-98.00%
3-Year Shareholders Equity Growth per Share48.59%
Receivables Growth128.68%
Inventory Growth25.72%
Asset Growth-15.45%
Book Value per Share Growth-25.09%
Debt Growth11.10%
R&D Expense Growth0.66%
SGA Expenses Growth-7.26%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 200,326,668.35, captures the company's total value, considering both debt and equity. Income quality, 0.62, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.85, gauges operational efficiency, while the research and development to revenue, 57.08%, highlights investment in innovation. The ratio of intangibles to total assets, 13.19%, indicates the value of non-physical assets, and capex to operating cash flow, 18.99%, measures reinvestment capability.

Enterprise Value200,326,668.35
Income Quality0.62
Sales General and Administrative to Revenue0.85
Research and Development to Revenue57.08%
Intangibles to Total Assets13.19%
Capex to Operating Cash Flow18.99%
Capex to Revenue-14.79%
Capex to Depreciation-110.68%
Stock-Based Compensation to Revenue24.44%
Graham Number8.01
Return on Tangible Assets-44.13%
Graham Net Net1.28
Working Capital112,426,000
Tangible Asset Value124,257,000
Net Current Asset Value93,333,000
Average Receivables10,927,000
Average Payables4,218,500
Average Inventory5,819,000
Days Sales Outstanding89
Days Payables Outstanding32
Days of Inventory On Hand92

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.15, and the price to book ratio, 2.15, reflect the market's valuation relative to the company's book value. The price to sales ratio, 5.23, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -5.68, and price to operating cash flows, -6.76, gauge market valuation against cash flow metrics.

Price Book Value Ratio2.15
Price to Book Ratio2.15
Price to Sales Ratio5.23
Price Cash Flow Ratio-6.76
Price Earnings to Growth Ratio0.05
Enterprise Value Multiple-6.47
Price Fair Value2.15
Price to Operating Cash Flow Ratio-6.76
Price to Free Cash Flows Ratio-5.68
Price to Tangible Book Ratio2.01
Enterprise Value to Sales3.21
Enterprise Value Over EBITDA-2.92
EV to Operating Cash Flow-4.12
Earnings Yield-25.90%
Free Cash Flow Yield-18.95%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of SOPHiA GENETICS SA (SOPH) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -4.130 in 2024.

What is the ticker symbol of SOPHiA GENETICS SA stock?

The ticker symbol of SOPHiA GENETICS SA stock is SOPH.

What is company IPO date?

IPO date of SOPHiA GENETICS SA is 2021-07-23.

What is company current share price?

Current share price is 5.000 USD.

What is stock market cap today?

The market cap of stock today is 326507000.000.

What is PEG ratio in 2024?

The current 0.048 is 0.048 in 2024.

What is the number of employees in 2024?

In 2024 the company has 430.